Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Non-Current Deffered Revenue (2020 - 2025)

Definitive Healthcare's Non-Current Deffered Revenue history spans 6 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue rose 7346.88% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, up 7346.88%, while the annual FY2025 figure was $2.4 million, 7346.88% up from the prior year.
  • Non-Current Deffered Revenue reached $2.4 million in Q4 2025 per DH's latest filing, up from $40000.0 in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.8 million in Q1 2025 to a low of $4000.0 in Q2 2024.
  • Average Non-Current Deffered Revenue over 5 years is $466833.3, with a median of $193000.0 recorded in 2022.
  • Peak YoY movement for Non-Current Deffered Revenue: crashed 97.33% in 2024, then skyrocketed 30900.0% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $412000.0 in 2021, then crashed by 42.72% to $236000.0 in 2022, then crashed by 96.19% to $9000.0 in 2023, then surged by 255.56% to $32000.0 in 2024, then soared by 7346.88% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Non-Current Deffered Revenue are $2.4 million (Q4 2025), $40000.0 (Q3 2025), and $574000.0 (Q2 2025).